Osteoarthritis: Pathobiology-targets and ways for therapeutic intervention

被引:100
作者
Aigner, T.
Sachse, A.
Gebhard, P. M.
Roach, H. I.
机构
[1] Univ Leipzig, Inst Pathol, D-04103 Leipzig, Germany
[2] Univ Jena, Dept Orthoped, D-07607 Eisenberg, Germany
[3] Univ Southampton, Bone & Joint Res Grp, Div Dev Origins Hlth & Dis, Gen Hosp, Southampton SO16 6YD, Hants, England
关键词
cartilage; drugs; joints; chondrocytes; senescence; cartilage regeneration;
D O I
10.1016/j.addr.2006.01.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Osteoarthritis is first and foremost the ongoing destruction of the articular cartilages of joints. Therefore, the extracellular matrix and the cells of the articular cartilages are the primary targets of osteoarthritis therapy. This tries to inhibit enzymatic destruction of the extracellular cartilage matrix as well as the modification of the cellular phenotype of the chondrocytes: cell degeneration and cell death are alongside anabolic activation and stabilization of the cellular phenotype of major interest. However, apart from the cartilage and its cells, other tissues of the joints are also important for the symptoms of the disease, which basically all originate outside the articular cartilage. In addition, changes in the subchondral bone as well as the synovial capsule and membrane are important at least for the progression of the disease process. All the named tissues offer different directions and ways for therapeutic intervention. (c) 2006 Elsevier B.V All rights reserved.
引用
收藏
页码:128 / 149
页数:22
相关论文
共 179 条
[1]  
Aigner T, 1999, ARTHRITIS RHEUM, V42, P1443, DOI 10.1002/1529-0131(199907)42:7<1443::AID-ANR18>3.0.CO
[2]  
2-A
[3]   Functional genomics of osteoarthritis - On the way to evaluate disease hypotheses [J].
Aigner, T ;
Bartnik, E ;
Sohler, F ;
Zimmer, R .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2004, (427) :S138-S143
[4]   Apoptosis in ostemithritis [J].
Aigner, T ;
Kim, HA ;
Roach, HI .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (03) :639-+
[5]   ACTIVATION OF COLLAGEN TYPE-II EXPRESSION IN OSTEOARTHRITIC AND RHEUMATOID CARTILAGE [J].
AIGNER, T ;
STOSS, H ;
WESELOH, G ;
ZEILER, G ;
VONDERMARK, K .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1992, 62 (06) :337-345
[6]  
Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO
[7]  
2-H
[8]   Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: A hypothesis [J].
Aigner, T ;
Dudhia, J .
ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (05) :287-291
[9]   Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage [J].
Aigner, T ;
Vornehm, SI ;
Zeiler, G ;
Dudhia, J ;
vonderMark, K ;
Bayliss, MT .
ARTHRITIS AND RHEUMATISM, 1997, 40 (03) :562-569
[10]   INDEPENDENT EXPRESSION OF FIBRIL-FORMING COLLAGEN-I, COLLAGEN-II, AND COLLAGEN-III IN CHONDROCYTES OF HUMAN OSTEOARTHRITIC CARTILAGE [J].
AIGNER, T ;
BERTLING, W ;
STOSS, H ;
WESELOH, G ;
VONDERMARK, K .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :829-837